Search market news

AT&T Beats Q3 Revenue and Profit Estimates, Raises 2026 Outlook

Cell — engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted

(This story was generated using AI and automation, please see disclaimer ) Overview Cell-engineering firm's preliminary Q3 revenue rose 26% yr/yr, beating analyst expectations Company raised full-year 2026 revenue guidance to about $34 mln Q3 results driven by accelerated instrument purchasing from a large customer Out

Johnson & Johnson Q3 sales rise on MedTech growth, lifts 2026 outlook

(This story was generated using AI and automation, please see disclaimer ) Overview US healthcare conglomerate's Q3 sales rose 5.9%, slightly beating analyst expectations Adjusted EPS for Q3 was $2.59, beating analyst expectations Company raised 2026 sales and adjusted EPS guidance Outlook Johnson & Johnson raises 2026

UnitedHealth Group raises profit forecast on third — quarter earnings beat

UnitedHealth Q3 adjusted profit beats LSEG estimate Company raises 2026 forecast to at least $20.50 per share Medical cost ratio improves to 88.4%, beats estimates By Amina Niasse NEW YORK, Oct 13 (Reuters) — UnitedHealth Group on Tuesday raised its 2026 profit forecast as the company tightened spending on medical cost

Levi Strauss beats Q3 estimates, raises full-year profit outlook

Levi Strauss reported adjusted fiscal third-quarter earnings of 48 cents a share on $1.61 billion in revenue, topping profit expectations but missing on sales. The company also raised its full-year adjusted earnings and organic revenue outlooks, saying tariff refunds helped profit.

DocuSign raises fiscal 2027 ARR guidance after Q2 results

DocuSign reported Q2 revenue of $876 million, up 9% year over year, with a 32% operating margin and about $300 million in free cash flow. It also raised fiscal 2027 ARR guidance and said IAM now accounts for 15.1% of total ARR.

Global-e Raises 2026 Outlook

Global-e reports Q2 revenue of $299 million, beating estimates, and raises full-year outlook